12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Mayne Pharma Group. Ltd., Metrics deal

Mayne will acquire contract development service and generics manufacturing company Metrics for $105 million up front and up to $15 million in milestones payments based on...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >